Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease
ABSTRACT: Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide. NAFLD is the most frequently diagnosed chronic liver disease, affecting 20-30% of the general population. Furthermore, its prevalence is predicted to increase exponentially in the next decades, concomitan...
- Autores:
-
Restrepo Gutiérrez, Juan Carlos
Dirchwolf, Melisa
Álvares da Silva, Mário Reis
Barrera, Francisco
Benítez, Carlos
Castellanos Fernandez, Marlene
Castro Narro, Graciela
Chávez Tapia, Norberto
Chiodi, Daniela
Cotrim, Helma
Cusi, Kenneth
Pinto Marques Souza de Oliveira, Claudia
Díaz, Javier
Fassio, Eduardo
Gerona, Solange
Girala, Marcos
Hernández, Nelia
Marciano, Sebastián
Masson, Walter
Méndez Sánchez, Nahum
Leite, Nathalie
Lozano, Adelina
Padilla, Martín
Panduro, Arturo
Paraná, Raymundo
Parise, Edison
Pérez, Marlene
Poniachik, Jaime
Arab, Juan Pablo
Ruf, Andrés
Silva, Marcelo
Tagle, Martín
Tapias, Monica
Torres, Kenia
Vilar Gómez, Eduardo
Costa Gil, José Eduardo
Gadano, Adrian
Arrese, Marco
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/40488
- Acceso en línea:
- https://hdl.handle.net/10495/40488
- Palabra clave:
- Algoritmos
Algorithms
Enfermedad del Hígado Graso no Alcohólico
Non-alcoholic Fatty Liver Disease
América Latina
Latin America
Hígado Graso
Fatty Liver
Fibrosis
Cirrhosis
https://id.nlm.nih.gov/mesh/D000465
https://id.nlm.nih.gov/mesh/D065626
https://id.nlm.nih.gov/mesh/D007843
https://id.nlm.nih.gov/mesh/D005234
https://id.nlm.nih.gov/mesh/D005355
- Rights
- openAccess
- License
- http://creativecommons.org/licenses/by-nc-nd/2.5/co/
| Summary: | ABSTRACT: Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide. NAFLD is the most frequently diagnosed chronic liver disease, affecting 20-30% of the general population. Furthermore, its prevalence is predicted to increase exponentially in the next decades, concomitantly with the global epidemic of obesity, type 2 diabetes mellitus (T2DM), and sedentary lifestyle. NAFLD is a clinical syndrome that encompasses a wide spectrum of associated diseases and hepatic complications such as hepatocellular carcinoma (HCC). Moreover, this disease is believed to become the main indication for liver transplantation in the near future. Since NAFLD management represents a growing challenge for primary care physicians, the Asociación Latinoamericana para el Estudio del Hígado (ALEH) has decided to organize this Practice Guidance for the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease, written by Latin-American specialists in different clinical areas, and destined to general practitioners, internal medicine specialists, endocrinologists, diabetologists, gastroenterologists, and hepatologists. The main purpose of this document is to improve patient care and awareness of NAFLD. The information provided in this guidance may also be useful in assisting stakeholders in the decision-making process related to NAFLD. Since new evidence is constantly emerging on different aspects of the disease, updates to this guideline will be required in future. Keywords: Cirrhosis; Clinical practice guidance; Fatty liver; MAFLD; NAFLD; NASH; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Steatosis. |
|---|
